Sutro Biopharma, Inc. Share Price
NASDAQ: STROHealthcare
Live Sutro Biopharma, Inc. Share Price Chart
O H L
Sutro Biopharma, Inc. Performance Overview
Days Range
▼
$15.32Low
$15.56High
Markets Today
| Previous Close | $15.48 |
|---|---|
| Open | $15.32 |
| Volume | 29,894 |
| Day's Range | $15.32 - $15.56 |
| 52W Range | $7.15 - $43.85 |
| Market Cap | $258.67 M |
Historical Performance
| 1M Returns | -29.76 |
|---|---|
| 3M Returns | -47.76 |
| 6M Returns | -28.94 |
| 1Y Returns | +71.47 |
| 5Y Returns | -92.13 |
| 10Y Returns | NA |
Sutro Biopharma, Inc. Fundamentals
| Market Cap | $258.67 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $102.48 M |
| ROE TTM | N/A |
| EPS TTM | $-17.32 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-97.63 M |
| Profit Margin | -186.45 |
| Market Cap | $258.67 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $102.48 M |
| ROE TTM | N/A |
| EPS TTM | $-17.32 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-97.63 M |
| Profit Margin | -186.45 |
Sutro Biopharma, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $17.40 M | $63.74 M | $9.69 M | $11.65 M | $14.52 M | $9.84 M |
| Gross Profit + | $17.40 M | $63.74 M | $9.69 M | $11.65 M | $14.52 M | $9.84 M |
| Operating Income | -$68.51 M | -$3.35 M | -$48.46 M | -$38.05 M | -$29.66 M | -$29.89 M |
| EBITDA | -$45.57 M | $16.98 M | -$37.00 M | -$32.03 M | -$28.34 M | -$28.43 M |
| Interest Expense | -$9.34 M | -$9.65 M | -$9.67 M | -$9.55 M | -$9.47 M | -$9.86 M |
| Depreciation | $22.94 M | $20.32 M | $11.46 M | $6.02 M | $1.32 M | $1.46 M |
| Income Before Tax | -$75.96 M | -$11.52 M | -$56.86 M | -$46.84 M | -$38.50 M | -$38.53 M |
| Income Tax Expense | $7.00 K | -$18.00 K | $0 | -$82.00 K | -$15.00 K | $1.00 K |
| Net Income + | -$75.97 M | -$11.50 M | -$56.86 M | -$46.76 M | -$38.48 M | -$38.53 M |
| Net Profit Margin | -436.62% | -18.04% | -586.58% | -401.49% | -264.99% | -391.64% |
Sutro Biopharma, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $84.00 K | $85.00 K | $85.00 K | $9.00 K | $17.00 K | $17.00 K |
| Reserve & Surplus | -$862.85 M | -$874.35 M | -$931.16 M | -$977.94 M | -$1.02 B | -$1.06 B |
| Non-Current Liabilities | $214.19 M | $220.22 M | $225.03 M | $231.15 M | $238.06 M | $244.88 M |
| Current Liabilities | $133.05 M | $74.25 M | $71.89 M | $75.13 M | $70.81 M | $52.90 M |
| Total Liabilities | $347.24 M | $294.47 M | $296.93 M | $306.28 M | $308.88 M | $297.78 M |
| Fixed Assets | $16.80 M | $14.98 M | $13.35 M | $10.65 M | $9.36 M | $8.36 M |
| Current Assets | $287.41 M | $231.63 M | $182.11 M | $150.93 M | $220.97 M | $175.65 M |
| Total Assets | $321.43 M | $262.36 M | $209.66 M | $173.83 M | $241.99 M | $194.46 M |
Sutro Biopharma, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$75.97 M | -$11.50 M | -$56.86 M | -$46.76 M | -$38.48 M | -$38.53 M |
| Operating Cash Flow | -$67.88 M | -$44.72 M | -$38.19 M | -$26.43 M | -$42.26 M | -$38.29 M |
| Investing Cash Flow | -$16.26 M | $2.58 M | $39.99 M | $18.70 M | -$45.26 M | $19.36 M |
| Financing Cash Flow | $66.00 K | -$60.00 K | $102.00 K | -$64.00 K | $103.08 M | -$418.00 K |
| Change in Cash | -$84.08 M | -$42.20 M | $1.90 M | -$7.80 M | $15.55 M | -$19.35 M |
Sutro Biopharma, Inc. Return Calculator
The Sutro Biopharma, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$767
Invested Amount$10,000
Est. Returns$-9,233
About Sutro Biopharma, Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Popular Stocks
FAQs
What is the share price of Sutro Biopharma, Inc. today?
Sutro Biopharma, Inc. (STRO) share price as of September 18, 2026 is $15.09. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Sutro Biopharma, Inc.?
Yes, Indian Investors can invest in the Sutro Biopharma, Inc. (STRO) Share by opening an international trading account with Angel One.
How can I purchase Sutro Biopharma, Inc. shares in India?
Purchasing Sutro Biopharma, Inc. (STRO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Sutro Biopharma, Inc. (STRO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Sutro Biopharma, Inc.?
Yes, you can purchase fractional shares of Sutro Biopharma, Inc. (STRO) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Sutro Biopharma, Inc.?
The market capitalization of Sutro Biopharma, Inc. on September 18, 2026, is $258.67 M.
In which sector Sutro Biopharma, Inc. belongs?
Sutro Biopharma, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Sutro Biopharma, Inc. stocks?
In order to invest in Sutro Biopharma, Inc. (STRO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
